Results 231 to 240 of about 117,188 (306)

Opioid Modulation of Differential Gene Expression and Neuronal Differentiation in the Ventricular-subventricular Zone of Adult Male Zebra Finches. [PDF]

Ann Neurosci
Din U, Banerjee S, Iyengar S.
europepmc   +1 more source

Effect of butorphanol in combination with xylazine during castration of calves: A randomised trial under field conditions

Veterinary Record, EarlyView.
Abstract Background In horses, cats and dogs, the opioid butorphanol has been proven effective in management of visceral pain and for peri‐ and postoperative pain relief. The aim of this study was to evaluate physiological responses and indicators of noxious stimuli when adding butorphanol to xylazine for sedation of bull calves during surgical ...
Axel Sannö, Lovisa Snygg, Maja Wiklund, Görel Nyman   +3 more
wiley   +1 more source

Intravenous paracetamol does not have significant opioid‐sparing effects when used as part of a multimodal analgesic protocol in dogs undergoing elective orthopaedic surgery

Veterinary Record, EarlyView.
Abstract Background Data evaluating paracetamol combined with NSAIDs in dogs are scarce. Results of clinical studies in dogs investigating intravenous paracetamol vary. Methods Dogs were randomised to either receive 10 mg/kg paracetamol intravenously after induction of anaesthesia and every 8 hours during hospitalisation (test) or not (control).
Robin Stallard, Julia Deutsch, Joanna Murrell   +2 more
wiley   +1 more source

Efficacy and safety of μ1-opioid receptor agonist (Taphalgin®) for emergency analgesia in outpatient practice. [PDF]

Saudi J Anaesth
Voloshin AG, Avetisova KN, Smirnova NV.
europepmc   +1 more source

The Dark Pyramid: Unpacking the Multidimensional Nature of the Dark Side of Leadership

British Journal of Management, EarlyView.
Abstract The dark side of leadership has been employed as an umbrella term to cover an array of concepts typically concerned with the dysfunctionality and/or toxicity of individual leaders. As the field of leadership studies moves towards ‘post‐heroic’ perspectives, we apply the same ontological positioning, adopting a ‘post‐villainous’ perspective in ...
Peter Stephenson, Richard Bolden, Morgen Witzel   +2 more
wiley   +1 more source

Divergence in μ and δ opioid receptor pharmacology in neurons and antinociceptive efficacy in neuropathic pain: Insights from MP135 and CYM51010. [PDF]

Br J Pharmacol
Inquimbert P, Fitterer C, Hugel S, Jesic M, Goumon Y, Andry V, Schneider S, Daubeuf F, Faouzi A, Doridot S, Majumdar S, Bihel F, Schmitt M, Massotte D.   +13 more
europepmc   +1 more source

Narrative review of the scientific and methodological explanations for 101 mechanisms of opioid tolerance. [PDF]

Pain Rep
Morgan MM, Bobeck EN.
europepmc   +1 more source

Clinical applications of esketamine: Current status and future perspectives. [PDF]

J Int Med Res
Li H, Deng J, Liu T, Zhang Y.
europepmc   +1 more source

The Role of Clinical Pharmacogenetics and Opioid Interactions in Pain Management: Current Evidence and Future Perspectives. [PDF]

Pharmaceutics
Di Salvo C, Valdiserra G, Balestrieri S, Beucci G, Paciulli G, Luculli GI, De Vita A, Fornai M, Di Paolo A, Antonioli L.   +9 more
europepmc   +1 more source

Opioid Receptors

, 2009
openaire   +1 more source